HomeInsightsStock Comparison

Granules India Ltd vs Morepen Laboratories Ltd Stock Comparison

Granules India Ltd vs Morepen Laboratories Ltd Stock Comparison

Last Updated on: Jul 04, 2025

Key Highlights

  • The Latest Trading Price of Granules India Ltd is ₹ 493.5 as of 04 Jul 16:01.
  • The P/E Ratio of Granules India Ltd changed from 10.9 on March 2020 to 25.7 on March 2024 . This represents a CAGR of 18.71% over 5 yearsThe P/E Ratio of Morepen Laboratories Ltd changed from 12.7 on March 2020 to 22.4 on March 2024 . This represents a CAGR of 12.02% over 5 years.
  • The Market Cap of Granules India Ltd changed from ₹ 3650 crore on March 2020 to ₹ 10420 crore on March 2024 . This represents a CAGR of 23.34% over 5 yearsThe Market Cap of Morepen Laboratories Ltd changed from ₹ 429.13 crore on March 2020 to ₹ 2149 crore on March 2024 . This represents a CAGR of 38.03% over 5 years.
  • The revenue of Granules India Ltd for the Mar '25 is ₹ 1230 crore as compare to the Dec '24 revenue of ₹ 1143 crore. This represent the growth of 7.59% The revenue of Morepen Laboratories Ltd for the Mar '25 is ₹ 470.46 crore as compare to the Dec '24 revenue of ₹ 458.12 crore. This represent the growth of 2.69%.
  • The ebitda of Granules India Ltd for the Mar '25 is ₹ 285.03 crore as compare to the Dec '24 ebitda of ₹ 235.97 crore. This represent the growth of 20.79% The ebitda of Morepen Laboratories Ltd for the Mar '25 is ₹ 46.85 crore as compare to the Dec '24 ebitda of ₹ 41.48 crore. This represent the growth of 12.95%.
  • The net profit of Granules India Ltd changed from ₹ 47.9 crore to ₹ 152.03 crore over 8 quarters. This represents a CAGR of 78.15% The net profit of Morepen Laboratories Ltd changed from ₹ 14.63 crore to ₹ 20.31 crore over 8 quarters. This represents a CAGR of 17.82% .
  • The Dividend Payout of Granules India Ltd changed from 5.72 % on March 2020 to 8.34 % on March 2024 . This represents a CAGR of 7.83% over 5 yearsThe Dividend Payout of Morepen Laboratories Ltd changed from 0 % on March 2020 to 0 % on March 2024 . This represents a CAGR of 0.0% over 5 years.

Share Price

* All values are in Rupees

P/E Ratio Over Time

No data available

Market Cap Over Time

No data available

* All values are in crore

Historical Share Prices

* All values are in Rupees

Revenue Over Time

No data available

* All values are in crore

EBITDA Over Time

No data available

* All values are in crore

Net Profit Over Time

No data available

* All values are in crore

Dividend Payout Over Time

No data available

* All values are in %

About Granules India Ltd

  • Granules India Limited is a large-scale vertically integrated company founded in March, 1991 manufacturing Active Pharmaceutical Ingredient (API), Pharmaceutical Formulation Intermediate (PFI) and Finished Dosage (FD).
  • With a strong presence across all three vertical, the company has created a leadership position in the off-patent drugs segment along with ensuring a strong presence in first line of defense' products such as Paracetamol, Ibuprofen, Metformin and Guaifenesin.
  • Granules India is the preferred supplier for some of the world's leading pharma branded and generics companies.
  • The company has one of largest PFI and single site FD facilities in the world.
  • It is also home to one of the World's largest Paracetamol API facilities. Company's research center at Pragathi Nagar, Hyderabad, spread across an area of 15,000 square feet, epitomizes the company's focus on research and development.

About Morepen Laboratories Ltd

  • Morepen Laboratories Limited is an India-based pharmaceutical company.
  • Its products include Loratadine, Montelukast Sodium, Atorvastatin Calcium and Sultamicillin.
  • The company markets formulation products in various therapeutic categories, such as antibiotics, gastrointestinal, respiratory, analgesic, antiallergic and neuropsychiatry with brands, such as Saltum, Saltumax, Cefpopen, Cefpen-S, Dom-DT, Acifix, Rabipen- DSR and Montelast.
  • It has new products added to the therapeutic categories, including Kilbac, Ducal D, Aclomore and Montelast-L. The company has three state-of-the-art manufacturing plants in the northern state of Himachal Pradesh (HP) in India.
  • The main plant at Parwanoo is inspected and approved by United States Food and Drug Administration (USFDA) for production of Loratadine, which is the best selling anti-allergy drug globally.

Granules India Ltd News Hub

News

Granules India arm receives one observation from USFDA for U.S. facility

In a regulatory filing, the company stated that the USFDA conducted a Pre-Approval Inspect...

Read more

28 Jun 2025 15:38

News

Granules India receives one observation from USFDA following inspection at Telangana facility

In a regulatory filing, the company stated that the USFDA conducted the inspection from 16...

Read more

23 Jun 2025 09:36

News

Granules India allots Equity shares

Granules India has approved the allotment of 1,00,000 equity shares in consequence of the ...

Read more

17 Jun 2025 11:30

News

Granules India announces cessation of Vice President & Head- IT

Granules India announced that Krishnamohan B., shall to be the Senior Management Personnel...

Read more

02 Jun 2025 12:46

News

Granules India to convene AGM

Granules India announced that the 34th Annual General Meeting(AGM) of the company will be ...

Read more

28 May 2025 14:10

News

Board of Granules India recommends final dividend

Granules India announced that the Board of Directors of the Company at its meeting held on...

Read more

28 May 2025 14:11

Morepen Laboratories Ltd News Hub

News

Morpen Labs incorporates subsidiary in Dubai

The newly formed wholly owned subsidiary namely Morepen Labs ' FZCO, will trade in pharmac...

Read more

19 Jun 2025 08:44

News

Board of Morepen Laboratories approves availing of working capital loan of Rs 50 cr

The Board of Morepen Laboratories at its meeting held on 23 May 2025 has approved inter-al...

Read more

23 May 2025 10:25

News

Board of Morepen Laboratories notes incorporation of step-down subsidiary in Dubai

The Board of Morepen Laboratories at its meeting held on 12 May 2025 has noted the decisio...

Read more

12 May 2025 18:29

News

Board of Morepen Laboratories recommends Final Dividend

Morepen Laboratories announced that the Board of Directors of the Company at its meeting h...

Read more

12 May 2025 16:11

News

Morepen Laboratories to announce Quarterly Result

Morepen Laboratories will hold a meeting of the Board of Directors of the Company on 12 Ma...

Read more

06 May 2025 11:55

News

Morepen receives CDSCO nod to conduct BE studies for Resmetirom

Morepen Laboratories has got clearance from Subject Expert Committee (SEC) of Central Drug...

Read more

29 Apr 2025 09:07

SWOT Analysis Of Granules India Ltd

Strength

4

S

Weakness

1

W

Opportunity

0

O

Threats

1

T

SWOT Analysis Of Morepen Laboratories Ltd

Strength

2

S

Weakness

2

W

Opportunity

0

O

Threats

0

T

BlinkX Score for Granules India Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

BlinkX Score for Morepen Laboratories Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

FAQs for the comparison of Granules India Ltd and Morepen Laboratories Ltd

Which company has a larger market capitalization, Granules India Ltd or Morepen Laboratories Ltd?

Market cap of Granules India Ltd is 11,891 Cr while Market cap of Morepen Laboratories Ltd is 3,503 Cr

What are the key factors driving the stock performance of Granules India Ltd and Morepen Laboratories Ltd?

The stock performance of Granules India Ltd and Morepen Laboratories Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Granules India Ltd and Morepen Laboratories Ltd?

As of July 4, 2025, the Granules India Ltd stock price is INR ₹490.1. On the other hand, Morepen Laboratories Ltd stock price is INR ₹63.94.

How do dividend payouts of Granules India Ltd and Morepen Laboratories Ltd compare?

To compare the dividend payouts of Granules India Ltd and Morepen Laboratories Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions